Skip to content
Newsletter
Toggle navigation
Newsletter
Search for:
Search
About ANCA vasculitis
Toggle menu
What is ANCA vasculitis?
Causes
Symptoms
Diagnosis
Prognosis
Types
Living with ANCA vasculitis
Treatment
Toggle menu
Approved treatments
Fasenra
Nucala
Rituximab
Tavneos
Experimental treatments
News
Columns
Toggle menu
Truth Be Told
— Sarah Jones
Archived columns
Veni, Vidi, Vascie
— Suzanne DePaolis
One Wild Ride
— Sara Amodio
Be You, Be Rare
— Brandon Hudgins
(In)visible Journey
— Sandra Ross
Peaceful Chaos
— Allison Ross
Advocacy partners
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Viatcheslav Vlassov, —
Articles by Viatcheslav Vlassov
Recent Posts
TWEAK protein in urine could be biomarker of AAV disease activity
New deal aims to develop, market povetacicept for AAV in Asia
The things we don’t say: Why vasculitis patients might stay silent
New AAV treament guidelines in UK recommend rituximab use
Abatacept fails to show benefit for non-severe GPA in clinical trial
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Email Address
(Required)
Email
This field is for validation purposes and should be left unchanged.
Δ
